OBJECTIVE:To investigate the application status of stains in outpatient department of Shanghai the Fifth People’s Hospital of Fudan University ( hereinafter referred to as “our hospital”) , so as to promote rational drug use in clinic.METHODS:Retrospectively statistical analysis was conducted on the consumption sum , defined daily dose system (DDDs), defined daily cost (DDC) of stains in outpatient department of our hospital during 2013-2015.RESULTS:The consumption amount of stains in outpatient department of our hospital were in a steady rising trend during 2013-2015, the consumption sum were respectively 4 207 662.70 yuan, 4 654 027.90 yuan and 5 284 590.80 yuan.Meanwhile, the consumption sum of Atorvastatin calcium tablets were respectively 2 704 128.4 yuan , 2 938 749.4 yuan and 2 815 185.9 yuan during 2013-2015, the constituent ratio of consumption sum were more than 50%, the constituent ratio of DDDs were 60%-70%.The consumption amount of Rosuvastatin calcium tablets were in a increasing tread , and the constituent ratio of consumption sum increased from 13.12%(107 128/816 336) in 2013 to 24.52%(231 756/945 101) in 2015. CONCLUSIONS:The applicational of stains in outpatient department of our hospital was basically rational .%目的：了解复旦大学附属上海市第五人民医院（以下简称“我院”）门诊他汀类药物的应用情况，以促进合理用药。方法：对2013—2015年我院门诊药房他汀类药物的销售金额、用药频度（ defined daily dose system ，DDDs）、限定日费用等进行回顾性统计分析。结果：2013—2015年我院门诊他汀类药物的用量呈稳定上升的态势，总销售金额分别为4207662．70、4654027．90、5284590．80元；3年来，阿托伐他汀钙片的销售金额分别为2704128．4、2938749．4、2815185．9元，各年销售金额构成比均超过50％，其DDDs构成比为60％～70％；瑞舒伐他汀钙片的用量逐年上升，其DDDs构成比从2013年的13．12％（107128／816336）上升至2015年的24．52％（231756／945101）。结论：我院门诊他汀类药物的使用基本合理。
展开▼
